Board Members

Doctor Mark Gluck was graduated at Harvard university and become speaker at Tukuba university in 2018.

Mark Gluck is co-director of the Rutgers Memory Disorders Project, and publisher of the public health newsletter, Memory Loss and the Brain. He is the co-author of Gateway to Memory: An Introduction to Neural Network Models of the Hippocampus and Memory (MIT Press, 2001), and an undergraduate textbook,Learning and Memory: From Brain to Behavior (Worth Publishers, 2007). He has edited several other books and has published over 60 scientific journal articles. His awards include the Distinguished Scientific Award for Early Career Contributions from the American Psychological Society and the Young Investigator Award for Cognitive and Neural Sciences from the Office of Naval Research. In 1996, he was awarded a National Science Foundation Presidential Early Career Award for Scientists and Engineers by President Bill Clinton.

Aging and Prodromal Alzheimer’s disease (including the African-American Brain Health Initiative)

What are the lifestyle and genetic factors that influence individual differences in learning and memory across the lifespan, especially those capabilities that rely on striatal and hippocampal systems? Both striatal and hippocampal circuits change with aging, and hippocampal-region dysfunction is among the first brain regions affected in the earliest prodromal stage of Alzheimer’s disease.

African Americans are known to be at elevated risk for age-related cognitive decline and memory loss, exhibiting twice the rate of Alzheimer’s disease (AD) as the general population. However, insufficient data exists on the role of within-group heterogeneity in mediating individual differences among African Americans in their risk for cognitive decline and AD.

Cognitive Components of Psychiatric and Neurological Disorders (including the Rutgers/Al-Quds Brain Research Exchange with the Palestinian Neuroscience Initiative).

Striatal and hippocampal dysfunction are found in several psychiatric and neurological disorders, including clinical depression (also known as major depressive disorder or MDD), Post-traumatic stress disorder (PTSD), and Parkinson’s disease.  The projects below employ a mix of methods to understand how the striatum and hippocampus are affected in these disorders, how neurocognitive assessments of learning behaviors can reveal underlying heterogeneity, what happens when patients are treated with medications that alter brain chemicals (especially serotonin and dopamine), and how computational modeling helps us understand the links between brain, behavior, and psychopathology.